Customized visual marking for medication labeling

• US 20080086339A1
• Filed: 09/27/2007
• Published: 04/10/2008
• Est. Priority Date: 06/23/2006
• Status: Abandoned Application

• Current Assignee: Searete LLC (Intellectual Ventures LLC)
• Original Assignee: Searete LLC (Intellectual Ventures LLC)
• Inventors: Jung, Edward, Malamud, Mark, Lord, Robert, Levien, Royce, Rinaldo, John, Wood, Lowell
• Application Number:
  US11/906,112
• Publication Number:
  US 20080086339A1
• Time in Patent Office: Days
• US Class Current: 705/3
• CPC Class Codes: B65B 61/025 for applying, e.g. printing, code or date marks on material prior to packaging
• CPC Class Codes: B65B 61/26 for marking or coding completed packages
• CPC Class Codes: G16H 10/60 for patient-specific data, e.g. for electronic patient records
• CPC Class Codes: G16H 10/65 stored on portable record carriers, e.g. on smartcards, RFID tags or CD
• CPC Class Codes: G16H 20/13 delivered from dispensers
• CPC Class Codes: G16H 70/40 relating to drugs, e.g. their side effects or intended usage

Abstract

Exemplary embodiments are disclosed that provide a customized technique for marking medication and other health-related products with a visual identifier that includes a recognizable symbolic aspect to facilitate proper administration of a substance dosage to designated patent. Display implementations of the visual identifier may be incorporated in various product packaging components. A possible supplemental visual identifier may be incorporated in the product packaging components to suggest recommended usage aspects of the substance dosage.

Claims

1. A method of marking a product comprising:

establishing a supplemental visual identifier for a medication or other health-related substance designated for use by a particular patient, which supplemental visual identifier includes one or more specified recognizable symbolic aspects that are intended to suggest proper administration of the medication or other health-related substance to the particular patient; and

displaying the supplemental visual identifier in close association with a substance dosage.

2. The method of claim 1 further comprising:

maintaining a cross-reference to correlate an applicable administration feature of the medication or other health-related substance with their respective specified recognizable symbolic aspect.

3. The method of claim 2 wherein said maintaining the cross-reference includes:

maintaining the cross-reference in one or more of the following locations;

database, patient ID tag, patient profile, medication list, patient chart, patient profile, pharmacy, nurse station, caretaker facility, caregiver instructions, healthcare regimen recommendations, product packaging, prescription document, prescription record, insurance record, user profile, and online profile.

4. The method of claim 2 further comprising:

keeping the cross-reference in a location that is accessible to a family member or caregiver or medical personnel having responsibility for the particular patient.

5. The method of claim 2 further comprising:

incorporating the cross-reference in human-readable form as part of packaging for the medication or other health-related substance.

6. The method of claim 1 wherein said establishing the supplemental visual identifier includes:

providing one or more non-alphanumeric symbolic aspects including a graphical aspect or an image aspect.

8. The method of claim 1 wherein said establishing the supplemental visual identifier includes:

providing a supplemental visual identifier that includes a combination of an alphanumeric aspect with one of the following;

graphical aspect, image aspect, non-alphanumeric aspect.

12. The method of claim 1 wherein said establishing the supplemental visual identifier includes:

implementing specified recognizable symbolic aspects that are correlated to one or more of the following types of substance dosage administration information applicable to the particular patient;

take internally, apply externally, dosage frequency, dosage amount, maximum dosage, substance storage environment, self-administered, caregiver administered, nurse administered, physician administered, keep securely locked away, maximum dosage, take with food, take with water, take with beverage, take before meal, take after meal, expiration, no refill, allowed refill, possible side effects, interactions, synergies, risk, warning, disclaimer, antidote, and ingredient.

13. The method of claim 1 wherein said establishing the supplemental visual identifier includes:

implementing specified recognizable symbolic aspects that are correlated to one or more of the following type of health-related issues;

pain, fever, anxiety, fall, injury, accident, bite, bleeding, inflammation, infection, drowsiness, insomnia, discomfort, stress, grooming, appearance, capability, performance, improvement, enhancement, curtailment, wellbeing, vitality, vigor, disability, phobia, malady, psychosis, environmental extremes, environmental exposure, dysfunction, disease symptom, chronic condition, mental acuity, emotional behavior, physical prowess, addiction, obsession, therapy, remedy, behavior, nutrition, diet, exercise, immunization, prevention, diagnosis, and treatment.

15. The method of claim 2 further comprising:

displaying the cross-reference in a location that is accessible to the particular patient.

17. The method of claim 1 further comprising:

providing one or more specified recognizable symbolic aspects for the supplemental visual identifier, which one or more specified recognizable symbolic aspects include one or more of the following type of distinguishable features;

alphanumeric, non-alphanumeric, alphanumeric abbreviation, graphical, image, icon, indicia, pattern, shape, format, and design.

19. The method of claim 1 further comprising:

providing one or more specified recognizable symbolic aspects that include at least one type of predetermined color or pattern or format.

24. The method of claim 1 wherein said providing the display scheme includes:

incorporating the visual identifier as an integral part of the substance dosage administered internally or externally to the particular patient.

31. The method of claim 1 wherein said providing the display scheme includes:

incorporating the visual identifier as an integral part of one or more separate packages for an individual component of the medication or other health-related substance.

34. The method of claim 1 further comprising:

incorporating one version of the supplemental visual identifier on packaging or labeling for the medication or other health-related substance; and

further incorporating another different version of the supplemental visual identifier as an integral part of the substance dosage.

35. The method of claim 1 wherein said providing the display scheme includes:

incorporating the visual identifier as a separate removable label attachable to the substance dosage or to packaging for the medication or other health-related substance.

37. The method of claim 1 wherein said providing the display scheme includes:

incorporating the supplemental visual identifier as a separate removable display element packaged with the medication or other health-related product.

7. (canceled)

9-11. -11. (canceled)

14. (canceled)

39. The method of claim 14 wherein said method is incorporated in one or more computer program products comprising a storage carrier medium or a communication carrier medium having program instructions encoded thereon for executing the method.

16. (canceled)

18. (canceled)

20-23. -23. (canceled)

25-30. -30. (canceled)

32-33. -33. (canceled)

36. (canceled)

38. (canceled)

40-41. -41. (canceled)

42. A medication or other health-related product comprising:

a health-related substance designated for use by a particular patient;

a supplemental visual identifier that includes one or more specified recognizable symbolic aspects that are intended to suggest proper administration of the health-related substance to a particular patient; and

a substance dosage to be administered internally or externally to the particular patient, wherein the supplemental visual identifier is incorporated as an integral display characteristic of the substance dosage and/or as a display element of a package or label in close association with the substance dosage.

43. The product of claim 42 wherein said supplemental visual identifier further includes:

a specified recognizable symbolic aspect intended to suggest proper administration of the substance dosage to one or more particular patients with a given symptom or deficiency.

44. The product of claim 42 wherein said supplemental visual identifier further includes:

one or more specified recognizable symbolic aspects intended to suggest proper administration of the substance dosage to one or more particular patients having a shared affiliation or grouping.

45. The product of claim 42 wherein said supplemental visual identifier further includes:

a specified recognizable symbolic aspect that is capable of suggesting proper administration of the substance dosage to one or more particular patients who are intended recipients of the substance dosage, wherein such supplemental visual identifier is recognizable without need of any scanner-like device.

46. The product of claim 42 further comprising:

cross-reference data information for correlating substance administration or health-related issues for one or more particular patients with their respective supplemental visual identifiers.

47. The product of claim 46 wherein said cross-reference data information includes:

cross-reference information accessible at one or more of the following locations;

database, patient ID tag, patient profile, medication list, patient chart, patient profile, pharmacy, nurse station, caretaker facility, caregiver instructions, healthcare regimen recommendations, product packaging, prescription document, prescription record, insurance record, user profile, and online profile.

48. The product of claim 42 wherein said substance dosage further includes:

a substance dosage that incorporates the supplemental visual identifier having a distinguishable shape or color or pattern or texture as an integral display characteristic of the substance dosage.

49. The product of claim 42 further comprising:

packaging or labeling for the substance dosage, wherein one or more of the following types of visual identifier for the particular patient are incorporated as a display element on the packaging or labeling;

name abbreviation, name initials, nickname, gender, age, height, weight, patient photo, address, attending physician, prescribing physician, caregiver, alias, avatar, buddy icon, URL, ID, affiliation, alphanumeric, text, image, graphic, color, pattern, format, shape, texture, and indicia.

51. The product of claim 42 further comprising:

separate dosages of different health-related substances that each display one or more specified recognizable symbolic aspects of the supplemental visual identifier.

52. The product of claim 42 wherein said health-related substance includes:

separate dosages of pharmaceutical and/or non-pharmaceutical products that each display one or more specified recognizable symbolic aspects of the supplemental visual identifier.

50. (canceled)

53. The product of claim 0 further comprising:

one or more additional components for use in connection with administration of the health-related substance, wherein such additional component displays one or more specified recognized symbolic aspects of the supplemental visual identifier.

54. A packaging system for medication or other health-related products, including:

a substance dosage designated for use by a particular patient;

a container for holding one or more substance dosages;

labeling that includes information to identify the particular patient;

a supplemental visual identifier that includes one or more recognizable symbolic aspects intended to suggest proper administration of the medication or other health-related product to the particular patient; and

a display implementation for the supplemental visual identifier, which display implementation is in close association with the substance dosage.

55. The packaging system of claim 54 wherein said display implementation includes:

a display implementation for a supplemental visual identifier having one or more of the following type of distinguishable characteristics;

abbreviation, color, shape, pattern, texture, format, graphic, image, text, alphanumeric, and indicia.

56. The packaging system of claim 55 wherein said display implementation includes:

the display implementation incorporated as an integral part of the container.

57. The packaging system of claim 55 wherein said display implementation includes:

the display implementation incorporated on the labeling.

58. The packaging system of claim 55 wherein said display implementation includes:

the display implementation incorporated as an integral part of the substance dosage.

59. The packaging system of claim 54 further comprising:

cross-reference data information for correlating one or more administration features with their respective supplemental visual identifiers, which cross-reference data information is available to the a family member or caregiver or medical personnel having responsibility for the particular patient.

60. The packaging system of claim 59 further comprising:

a data record for the cross-reference between the supplemental visual identifier and its correlated administration feature, which data record is accessible at one or more of the following locations;

database, patient ID tag, patient profile, medication list, patient chart, patient profile, pharmacy, nurse station, caretaker facility, caregiver instructions, healthcare regimen recommendations, product packaging, prescription document, prescription record, insurance record, user profile, and online profile.

61. The packaging system of claim 54 wherein said supplemental visual identifier includes:

a symbolic display element on one separate component of the packaging system that is correlated with a related symbolic display element on another component of the packaging system.

64. The packaging system of claim 61 wherein said symbolic display element includes:

a symbolic display element that serves a dual function intended to facilitate identification of a particular patient as well as intended to suggest proper administration of the health-related substance to the particular patient.

66. The packaging system of claim 54 wherein said supplemental visual identifier includes:

one or more specified recognizable symbolic aspects that are distinguishable as compared to the information to identify the particular patient.

67. The packaging system of claim 54 further comprising:

a cross-reference to correlate substance administration or health-related issues with their respective specified recognizable symbolic aspects, which cross reference is accessible to the particular patient.

68. The packaging system of claim of claim 54 wherein said display implementation for the supplemental visual identifier includes display elements that are capable of visual recognition without need of a scanner-like device.

62-63. -63. (canceled)

65. (canceled)

69. A packaging system for a health-related product, comprising:

a substance dosage of the health-related product that is designated for a particular patient;

a supplemental visual identifier that includes one or more specified recognizable symbolic aspects correlated by cross-reference to diagnostic or measurement or treatment or therapeutic administration features of the medication or other health-related product; and

one or more additional components for use in connection with such administration of the health-related product, wherein each such additional component displays one or more of the specified recognizable symbolic aspects of the supplemental visual identifier.

70. The packaging system of claim 69 further comprising:

cross-reference data information for correlating the particular patient with one or more specified recognizable symbol aspects of the supplemental visual identifier.

71. The system of claim 69 wherein said supplemental visual identifier includes:

a symbolic display element on one separate component of the packaging system that is correlated with a related symbolic display element on another component of the packaging system.

72. The system of claim 69 further comprising:

a display implementation that incorporates the supplemental visual identifier to be integral with the substance dosage.

73. The system of claim 69 further comprising:

a display implementation that incorporates the supplemental visual identifier to be integral with a packet or container for the substance dosage.

74. The system of claim 69 further comprising:

a display implementation that incorporates supplemental visual identifier to be integral with a label for the substance dosage.

75. A computer program product having carrier media for encoding one or more programs operable to perform a process, wherein said process comprises:

establishing a supplemental visual identifier that includes one or more specified symbolic aspects correlated with a diagnostic or measurement or treatment or therapeutic administration feature of a health-related product designated for a particular patient;

implementing a display scheme for incorporating a recognizable form of the supplemental visual identifier in close association with the health-related product; and

providing a cross-reference to correlate the administration feature with the supplemental visual identifier.

76. The computer program product of claim 75 wherein said process further includes:

maintaining a record that provides a cross-reference correlation between the supplemental visual identifier and the applicable administration feature of the health-related product.

77. The computer program product of claim 75 further comprising:

carrier media including a storage medium and/or a communication medium that incorporates program instructions for executing said process.